These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 21958302)

  • 1. Treatment of refractory pain with botulinum toxins--an evidence-based review.
    Jabbari B; Machado D
    Pain Med; 2011 Nov; 12(11):1594-606. PubMed ID: 21958302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin treatment of pain syndromes -an evidence based review.
    Safarpour Y; Jabbari B
    Toxicon; 2018 Jun; 147():120-128. PubMed ID: 29409817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum neurotoxins in the treatment of refractory pain.
    Jabbari B
    Nat Clin Pract Neurol; 2008 Dec; 4(12):676-85. PubMed ID: 19043424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin assessment, intervention and aftercare for paediatric and adult niche indications including pain: international consensus statement.
    Rawicki B; Sheean G; Fung VS; Goldsmith S; Morgan C; Novak I;
    Eur J Neurol; 2010 Aug; 17 Suppl 2():122-34. PubMed ID: 20633183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Naumann M; So Y; Argoff CE; Childers MK; Dykstra DD; Gronseth GS; Jabbari B; Kaufmann HC; Schurch B; Silberstein SD; Simpson DM;
    Neurology; 2008 May; 70(19):1707-14. PubMed ID: 18458231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
    Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical appraisal of the evidence for botulinum toxin type A in the treatment for cervico-thoracic myofascial pain syndrome.
    Desai MJ; Shkolnikova T; Nava A; Inwald D
    Pain Pract; 2014 Feb; 14(2):185-95. PubMed ID: 23692187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin type A in refractory chronic migraine: an open-label trial.
    Menezes C; Rodrigues B; Magalhães E; Melo A
    Arq Neuropsiquiatr; 2007 Sep; 65(3A):596-8. PubMed ID: 17876397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin type A in chronic plantar fasciitis: clinical effects one year after injection.
    Díaz-Llopis IV; Gómez-Gallego D; Mondéjar-Gómez FJ; López-García A; Climent-Barberá JM; Rodríguez-Ruiz CM
    Clin Rehabil; 2013 Aug; 27(8):681-5. PubMed ID: 23411793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new treatment paradigm for trigeminal neuralgia using Botulinum toxin type A.
    Guardiani E; Sadoughi B; Blitzer A; Sirois D
    Laryngoscope; 2014 Feb; 124(2):413-7. PubMed ID: 23818108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin-A for Painful Diabetic Neuropathy: A Meta-Analysis.
    Lakhan SE; Velasco DN; Tepper D
    Pain Med; 2015 Sep; 16(9):1773-80. PubMed ID: 25800040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intra-articular injection of botulinum toxin type A in refractory hemiplegic shoulder pain.
    Castiglione A; Bagnato S; Boccagni C; Romano MC; Galardi G
    Arch Phys Med Rehabil; 2011 Jul; 92(7):1034-7. PubMed ID: 21704782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of botulinum toxins for the management of chronic pain and headache: making the most of an evidence-based medicine approach for these rapidly evolving treatments.
    Argoff CE
    Pain Med; 2011 Nov; 12(11):1581-2. PubMed ID: 22082137
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply: Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: randomized, double-blind, noninferiority trial.
    Mueller J
    Mov Disord; 2009 May; 24(7):1098-9; author reply 1100. PubMed ID: 18942082
    [No Abstract]   [Full Text] [Related]  

  • 17. Is botulinum toxin A effective for the treatment of plantar fasciitis?
    Peterlein CD; Funk JF; Hölscher A; Schuh A; Placzek R
    Clin J Pain; 2012 Jul; 28(6):527-33. PubMed ID: 22673486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled study of the efficacy of the injection of botulinum toxin type A versus corticosteroids in chronic plantar fasciitis: results at one and six months.
    Díaz-Llopis IV; Rodríguez-Ruíz CM; Mulet-Perry S; Mondéjar-Gómez FJ; Climent-Barberá JM; Cholbi-Llobel F
    Clin Rehabil; 2012 Jul; 26(7):594-606. PubMed ID: 22144721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.